Imine-Oxazoline (ImOx): A

Elliot S Silk, Haozhe Zhu, Alexander G Shtukenberg, Tianning Diao

Abstract read

In one paragraph

Article in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elliot S SilkDepartment of Chemistry, New York University, 100 Washington Square East, New York, New York 10003, United States.

Haozhe ZhuDepartment of Chemistry, New York University, 100 Washington Square East, New York, New York 10003, United States.

Alexander G ShtukenbergDepartment of Chemistry, New York University, 100 Washington Square East, New York, New York 10003, United States.ORCID https://orcid.org/0000-0002-5590-4758

Tianning DiaoDepartment of Chemistry, New York University, 100 Washington Square East, New York, New York 10003, United States.ORCID https://orcid.org/0000-0003-3916-8372

Funding

Stereoselective Alkene Carbofunctionalization: Method Development and MechanismR01GM127778 · NIGMS · NEW YORK UNIVERSITY · PI Tianning Diao · 2019 to 2026

$3.1M

NIGMS NIH HHS R01 GM127778

6 · The paper itself

Abstract

Asymmetric catalysis relies on the design of chiral ligands, but the variety of nitrogen-based ligands remains limited. To address this gap, we have developed a class of

Indexed as

asymmetric catalysischiral ligandImOxnickelpalladiumredox active

Identifiers

PMID40636738

DOI10.1021/acscatal.5c03134

PMCPMC12235631

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.